Showing results (21-30 of 664) with videos related to
Sort By:
Pageof 67
Current Opinion in Pharmacology|January 5, 2002
Therapeutic options for the management of influenzaM G Ison, F G HaydenClinics in Laboratory Medicine|December 1, 1987
Antiviral chemotherapy and prophylaxis of viral respiratory diseaseS J Sperber, F G HaydenAntiviral Research|December 1, 1989
Protective effect of rhinovirus receptor blocking antibody in human fibroblast cellsS J Sperber, F G HaydenArchives of Family Medicine|October 14, 2000
Picornavirus infections: a primer for the practitionerH A Rotbart, F G HaydenThe Journal of Infectious Diseases|September 1, 1983
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illnessF G Hayden, J M GwaltneyThe Journal of Infectious Diseases|August 1, 1984
Intranasal interferon-alpha 2 treatment of experimental rhinoviral coldsF G Hayden, J M GwaltneyDrugs|November 7, 1998
New approaches to influenza chemotherapy. Neuraminidase inhibitorsD P Calfee, F G HaydenInfectious Disease Clinics of North America|June 1, 1987
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infectionsR L Tominack, F G HaydenJournal of Clinical Microbiology|September 1, 1985
Comparative susceptibilities of strain MRC-5 human embryonic lung fibroblast cells and the Cooney strain of human fetal tonsil cells for isolation of rhinoviruses from clinical specimensF C Geist, F G HaydenAntimicrobial Agents and Chemotherapy|June 1, 1982
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infectionF G Hayden, J M GwaltneyPageof 67